The comparison of post-treatment and baseline profiles of asthma patients showed that ligand-dependent nuclear receptor transcription coactivator activity, NAT activity, protein tyrosine kinase activity as well as ligand-dependent nuclear receptor, RNA polymerase II-activating transcription factor were downregulated after treatment with ICS/LABAs. This evidence concerns the gene BRD2 and asthma.